Treatment-Resistant Depression
Cyberonics sponsors symposium on latest therapeutic strategies for treatment-resistant depression
Published in Medical Letter on the CDC and FDA, August 13th, 2006
David L. Dunner, MD, director, Center for Anxiety and Depression, professor emeritus, Department of Psychiatry and Behavioral Sciences, University of Washington, served as moderator of the symposium, titled, "The Past, Present and Future Therapies for Treatment-Resistant Depression." The speakers reviewed new findings on the clinical use of various stimulation therapies, including VNS Therapy, and provided an update on the current...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Breast Cancer
Rho GTPase regulator promotes breast cancer cell invasiveness - Food Safety
Epidemiologic data is used to measure impact of food safety control programs - Retinoic Acid
Pharmacokinetics of 13-cis-retinoic acid or all-trans-retinoic acid in rats is presented - Addiction Medicine
Concurrent use of alcohol and prescription drugs were studied in a university population - Addiction Medicine
Social influences on adolescent alcohol use are explored - Addiction Medicine
Social network participation aids retention in therapeutic communities - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
